The FDA authorized the use of an experimental antibody treatment for Covid-19

Share on facebook
Share on twitter
Share on linkedin
Share on reddit


A healthcare worker conducts an antigen rapid test for COVID-19 during a mass screening for coronavirus to test 25 percent of the population in Burgos, northern Spain, on November 21, 2020. | CESAR MANSO/AFP via Getty Images

The treatment was given to Trump during the president’s bout with the virus in October.

Amid record levels of new Covid-19 infections and hospitalizations, the Food and Drug Administration announced Saturday that it would allow emergency use of an antibody drug treatment known as REGN-COV2 that helps immune systems fight the virus.

The treatment, developed by the biotech company Regeneron, consists of two antibodies called casirivimab and imdevimab that have thus far shown promising results in reducing the severity of the coronavirus when given to patients who have not yet developed symptoms requiring hospitalization. Another similar treatment, made by drug giant Eli Lilly, was approved earlier this month.

The Regeneron treatment received widespread attention after it was used to treat President Donald Trump during his bout with the virus in October. In a video released on October 7, Trump claimed — without evidence — that the…



Comments

Leave a Reply

Responses

Build for us, by us...

Social Community

Breaking News

Business Directory

Connections

Grow

Forge Your Kingdom...

Community is Everything: Build a tribe of inspiring friends. Build a community, of like-minds, who will give you the strength to act on your ideas and inspire you to be the best version of you.

Community

Connect, Share, & Grow! Share your stories!

Mobile Friendly

Access the community from any device.

Buy Black

Thousands of minority-owned businesses at your fingertips.